• The BCR-ABL - Quantitative test

    BCR-ABL Quantitative Test | Accurate Monitoring for Leukemia Detection

    د.إ3,250.00

    The BCR/ABL – Quantitative test is a highly sensitive molecular diagnostic assay used to detect and quantify the BCR-ABL fusion gene, a key biomarker in chronic myeloid leukemia (CML) and some acute lymphoblastic leukemias (ALL). Utilizing real-time PCR technology, it provides precise measurement of BCR-ABL transcript levels, enabling accurate disease monitoring and treatment response assessment.

    Sample Type : Whole Blood
    Methodology : Real time PCR
    TAT : 8-10 Days

    Add to cartDone
  • Cancer Marker

    Cancer Marker – Male

    د.إ650.00

    Includes the following parameters:

    • Alpha-Fetoprotein (AFP)
    • CA 19.9, Serum (Pancreatic Cancer Marker)
    • Carcinoembryonic Antigen (CEA), Serum
    • Prostate-Specific Antigen (PSA), Total Serum
    • Prostate-Specific Antigen (PSA), Free Serum
    • Human Chorionic Gonadotropin (HCG)
    Add to cartDone
  • Liquid HALLMARK (Liquid Biopsy)

    Liquid HALLMARK (Liquid Biopsy)

    د.إ13,000.00

    Liquid HALLMARK is a comprehensive liquid biopsy test that analyzes circulating tumor DNA (ctDNA) from a simple blood draw to detect and monitor cancer.

    Sample Type : Serum
    Methodology : Ultra-deep sequencing using Lucence’s proprietary AmpliMARK™ technology
    TAT : 8-10 Days

    Add to cartDone